Advances in allergic skin disease: omalizumab is a promising therapy for urticaria and angioedema.
Spector
Sheldon L
SL
Tan
Ricardo A
RA
D000707:Anaphylaxis / Q000453:epidemiology / Q000209:etiology / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000276:immunology*; D005512:Food Hypersensitivity / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007299:Insect Bites and Stings / Q000276:immunology*; D012871:Skin Diseases / Q000209:etiology / Q000276:immunology* / Q000628:therapy